الولايات المتحدة · منصات وبيانات · MarketBeat

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stock Has Average Target Price of $699.20 According to Analysts

نشره MarketBeat · الولايات المتحدة منذ 1 س

Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Get Free Report) have received an average rating of "Moderate Buy" from the eighteen ratings firms that are currently…

اقرأ المقال كاملًا على MarketBeat سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.marketbeat.com)

يستحق القراءة أيضًا

The Motley Fool

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stock Has Average Target Price of $699.20 According to Analysts

مشاركة

يستحق القراءة أيضًا

Prediction: These 3 Stocks Will 10X in the Next 20 Years

Nvidia to back four German AI startups as part of near-$10B European push

The world’s finance chiefs see new risks — and less China angst

Peloton COO Kirol sells $153,765 of company stock

Japan's 20-Year Government Bond Auction Draws Record Demand

AI applications expand, fueling China's economic growth